Vaxtracker is an innovative online active surveillance system that allows people to report how their child responded to a recently administered vaccine, by completing a web-based survey. Immunisation providers play an important role by encouraging parents/carers of patients to participate in the Vaxtracker program.
The project began in the Hunter New England Local Health District (LHD) in 2011. Vaxtracker is now being used by General Practices, Aboriginal Medical Services and Community Health in the Hunter New England LHD, Sydney Children's Hospitals, the Royal Children's Hospital (Melbourne), Lady Cilento Children's Hospital (Brisbane) and the Northern Territory Department of Health. These sites are using Vaxtracker to monitor the childhood influenza and DTPa vaccines (18 months and 4 year booster doses).
Vaxtracker is also being used to monitor the administration of the pneumococcal polysaccharide vaccine (23vPPV) or placebo in a large multi-site randomised control trial called AUSPICE.
Vaxtracker provides information to the AusVaxSafety network. AusVaxSafety is led by the National Centre for Immunisation, Research and Surveillance (NCIRS) and is funded by the Australia Government Department of Health. De-identified information collected via Vaxtracker and SmartVax are analysed and reported weekly to the Department of Health and the Therapeutic Goods Administration (TGA).
In 2014-16, we were able to demonstrate that the influenza vaccines registered and recommended for use in children under five years of age were safe. This information provides further encouragement to health professionals and parents/carers considering the influenza vaccine for their patients or children, in near real-time.
Participation is entirely voluntary and all individual information remains confidential. If you have any questions about Vaxtracker and AusVaxSafety please call 1800 750 566, or email email@example.com. For information on AusVaxSafety, please visit the NCIRS website under 'Surveillance'.